NCT03545503View on ClinicalTrials.gov

Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation

PHASE4CompletedINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 1, 2019

Study Completion Date

September 1, 2019

Conditions
Intubation Complication
Interventions
DRUG

Etomidate

Etomidate will be administered as the sedative for RSI on even days

DRUG

Ketamine

Ketamine will be administered as the sedative for RSI on odd days

Trial Locations (1)

28401

New Hanover Regional Medical Center, Wilmington

All Listed Sponsors
collaborator

New Hanover Regional Medical Center

OTHER

lead

South East Area Health Education Center, Wilmington, NC

OTHER

NCT03545503 - Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation | Biotech Hunter | Biotech Hunter